Diabetes drug approved
The Scottish Medicines Consortium has approved the drug sitagliptin/metformin (Janumet) as an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units